Direct-to-consumer Disease Risk and Health Genetic Test Market Report – Research, Industry Analysis Reports and Market Demands

Global Direct-to-consumer Disease Risk and Health Genetic Test Market Growth 2019-2024

Request for Sample of this report

Buy now

Table of Content

2019-2024 Global Direct-to-consumer Disease Risk and Health Genetic Test Consumption Market Report

1 Scope of the Report

2 Executive Summary

2.1 World Market Overview
- 2.1.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Consumption 2014-2024
- 2.1.2 Direct-to-consumer Disease Risk and Health Genetic Test Consumption CAGR by Region
2.2 Direct-to-consumer Disease Risk and Health Genetic Test Segment by Type
- 2.2.1 Celiac Disease
- 2.2.2 Parkinson Disease
- 2.2.3 Alzheimer Disease
- 2.2.4 Other
2.3 Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Type
- 2.3.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Sale Price by Type (2014-2019)
2.4 Direct-to-consumer Disease Risk and Health Genetic Test Segment by Application
- 2.4.1 Online
- 2.4.2 Offline
2.5 Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Application
- 2.5.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Value and Market Share by Application (2014-2019)
- 2.5.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Sale Price by Application (2014-2019)

3 Global Direct-to-consumer Disease Risk and Health Genetic Test by Players

3.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share by Players
- 3.1.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Players (2017-2019)
- 3.1.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share by Players (2017-2019)
3.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Market Share by Players
- 3.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Players (2017-2019)
- 3.2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Market Share by Players (2017-2019)
3.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Sale Price by Players
3.4 Global Direct-to-consumer Disease Risk and Health Genetic Test Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Direct-to-consumer Disease Risk and Health Genetic Test by Regions

4.1 Direct-to-consumer Disease Risk and Health Genetic Test by Regions
- 4.1.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Regions
- 4.1.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Value by Regions
4.2 Americas Direct-to-consumer Disease Risk and Health Genetic Test Consumption Growth
4.3 APAC Direct-to-consumer Disease Risk and Health Genetic Test Consumption Growth
4.4 Europe Direct-to-consumer Disease Risk and Health Genetic Test Consumption Growth
4.5 Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test Consumption Growth

5 Americas

5.1 Americas Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Countries
- 5.1.1 Americas Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Countries (2014-2019)
- 5.1.2 Americas Direct-to-consumer Disease Risk and Health Genetic Test Value by Countries (2014-2019)
5.2 Americas Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Type
5.3 Americas Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Countries
- 6.1.1 APAC Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Countries (2014-2019)
- 6.1.2 APAC Direct-to-consumer Disease Risk and Health Genetic Test Value by Countries (2014-2019)
6.2 APAC Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Type
6.3 APAC Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Direct-to-consumer Disease Risk and Health Genetic Test by Countries
- 7.1.1 Europe Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Countries (2014-2019)
- 7.1.2 Europe Direct-to-consumer Disease Risk and Health Genetic Test Value by Countries (2014-2019)
7.2 Europe Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Type
7.3 Europe Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test by Countries
- 8.1.1 Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test Value by Countries (2014-2019)
8.2 Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Type
8.3 Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
10.2 Direct-to-consumer Disease Risk and Health Genetic Test Distributors
10.3 Direct-to-consumer Disease Risk and Health Genetic Test Customer

11 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Forecast

11.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Consumption Forecast (2019-2024)
11.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Forecast by Regions
- 11.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Forecast by Regions (2019-2024)
- 11.2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
11.7 Global Direct-to-consumer Disease Risk and Health Genetic Test Forecast by Type
11.8 Global Direct-to-consumer Disease Risk and Health Genetic Test Forecast by Application

12 Key Players Analysis

13 Research Findings and Conclusion

Description

The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.

According to this study, over the next five years the Direct-to-consumer Disease Risk and Health Genetic Test market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Direct-to-consumer Disease Risk and Health Genetic Test business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Direct-to-consumer Disease Risk and Health Genetic Test market by product type, application, key manufacturers and key regions and countries.

This study considers the Direct-to-consumer Disease Risk and Health Genetic Test value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Celiac Disease
Parkinson Disease
Alzheimer Disease
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Online
Offline

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Direct-to-consumer Disease Risk and Health Genetic Test consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Direct-to-consumer Disease Risk and Health Genetic Test market by identifying its various subsegments.
Focuses on the key global Direct-to-consumer Disease Risk and Health Genetic Test manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Direct-to-consumer Disease Risk and Health Genetic Test with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Direct-to-consumer Disease Risk and Health Genetic Test submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.